Clinical trial
A Study to Evaluate the Safety and Efficacy of Abatacept in Patients With…
NCT00442611 · Stanford University, Other · Completed
Key facts
| NCT number | NCT00442611 |
|---|---|
| Title | A Study to Evaluate the Safety and Efficacy of Abatacept in Patients With Diffuse Systemic Sclerosis (Scleroderma) |
| Official title | A Pilot Study to Evaluate the Safety and Efficacy of Abatacept in Patients With Systemic Sclerosis |
| Lead sponsor | Stanford University, Other |
| Collaborators | Bristol-Myers Squibb Industry |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Scleroderma, Diffuse, Systemic |
| Intervention type | Drug |
| Interventions | Abatacept, Placebo |
| Enrollment | 10 |
| Start date | Nov 1, 2008 |
| Primary completion | Jun 1, 2011 |
| Completion | Jun 1, 2011 |
| First posted | Mar 2, 2007 |
| Last update posted | Oct 31, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: